<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7175558\results\search\disease\results.xml">
  <result pre="doi: 10.1186/s40249-020-00655-w : Research Article Severity and outcomes of influenza-related" exact="pneumonia" post="in type A and B strains in China, 2013–2019"/>
  <result pre="Inconsistencies exist regarding the severity of illness caused by different" exact="influenza" post="strains. The aim of this study was to compare"/>
  <result pre="the clinical outcomes of hospitalized adults and adolescents with influenza-related" exact="pneumonia" post="(Flu-p) from type A and type B strains in"/>
  <result pre="Cox regression models were used to assess the effects of" exact="influenza" post="virus subtypes on clinical outcomes, and to explore the"/>
  <result pre="30-day mortality for Flu-p patients. Results In total, 963 laboratory-confirmed" exact="influenza" post="A-related pneumonia (FluA-p) and 386 influenza B-related pneumonia (FluB-p)"/>
  <result pre="for Flu-p patients. Results In total, 963 laboratory-confirmed influenza A-related" exact="pneumonia" post="(FluA-p) and 386 influenza B-related pneumonia (FluB-p) patients were"/>
  <result pre="In total, 963 laboratory-confirmed influenza A-related pneumonia (FluA-p) and 386" exact="influenza" post="B-related pneumonia (FluB-p) patients were included. Upon adjustment for"/>
  <result pre="963 laboratory-confirmed influenza A-related pneumonia (FluA-p) and 386 influenza B-related" exact="pneumonia" post="(FluB-p) patients were included. Upon adjustment for confounders, multivariate"/>
  <result pre="0.001) compared to FluB-p. Multivariate Cox regression models confirmed that" exact="influenza" post="A virus infection (hazard ratio: 2.637, 95% CI: 1.134–6.131,"/>
  <result pre="Clinical outcome Funding Beijing JishuitanHospitalZR-201921ChenLiang Background Influenza is a contagious" exact="respiratory disease" post="that is widespread across the globe. Despite advances in"/>
  <result pre="is widespread across the globe. Despite advances in medical technology," exact="influenza" post="causes considerable hospitalizations and mortality [1, 2]. It is"/>
  <result pre="is estimated that each year, 1 billion cases of symptomatic" exact="influenza" post="infection have occurred across the globe, including 3–5 million"/>
  <result pre="care unit (ICU) admissions and 12 000–79 000 deaths were associated with" exact="influenza" post="per year in the United States of America [4]."/>
  <result pre="the United States of America [4]. The disease burden of" exact="influenza" post="in Asia is similar to that of western countries"/>
  <result pre="or 0.6% of the global income [7]. For these reasons," exact="influenza" post="epidemics are regarded as the greatest threat to the"/>
  <result pre="cough. Kilbourne suggested that the disease features caused by different" exact="influenza" post="virus subtypes are clinically indistinguishable [8]. Several studies have"/>
  <result pre="examined the hypothesis that the severity of illness caused by" exact="influenza" post="is associated with causal virus types. For example, Mosnier"/>
  <result pre="found that the clinical symptoms and outcomes for patients with" exact="influenza" post="A and B infections were comparable [9, 10]. Studies"/>
  <result pre="comparable [9, 10]. Studies by Kaji and colleagues showed that" exact="influenza" post="A infection was more severe than influenza B [11]."/>
  <result pre="colleagues showed that influenza A infection was more severe than" exact="influenza" post="B [11]. The outcomes of different studies have been"/>
  <result pre="understand the differences of the severity and outcomes between specific" exact="influenza" post="virus types is of great significance to arrange rational"/>
  <result pre="other clinical decisions in the management of severe influenza. Influenza-related" exact="pneumonia" post="(Flu-p) is the major kind of severe influenza, which"/>
  <result pre="Study design Patient recruitment We screened hospitalized patients positive for" exact="influenza" post="virus RNA at the microbiology labs of five tertiary"/>
  <result pre="as follows: (i) Aged ≤ 14 years; (ii) not classified as community-onset" exact="pneumonia" post="(pneumonia onset ≥ 48 h post-admission and hospitalized within the last"/>
  <result pre="28 days [13]), as it was difficult to determine whether nosocomial" exact="pneumonia" post="occurred after the onset the influenza; (iii) it has"/>
  <result pre="that the clinical characteristics and outcomes of immunocompromised patients with" exact="influenza" post="differ to those of immunocompetent hosts. So, those who"/>
  <result pre="were excluded [14]. Disease and treatment definitions Patients with influenza-related" exact="pneumonia" post="were defined during the influenza season and manifested with"/>
  <result pre="treatment definitions Patients with influenza-related pneumonia were defined during the" exact="influenza" post="season and manifested with respiratory symptoms and were positive"/>
  <result pre="season and manifested with respiratory symptoms and were positive for" exact="influenza" post="virus by reverse-transcription polymerase chain reaction (RT-PCR), together with"/>
  <result pre="All probability tests were two-tailed. To evaluate the impact of" exact="influenza" post="virus subtypes on illness severity and clinical outcomes (invasive"/>
  <result pre="previously shown to be associated with the clinical outcomes of" exact="influenza" post="patients and served as confounders [15]. According to the"/>
  <result pre="Flu-p patients, variables with P-values &amp;lt; 0.1 in univariate analysis and" exact="influenza" post="virus type A were entered into the multivariate Cox"/>
  <result pre="USA). Results Screening process We screened 3190 patients that were" exact="influenza" post="RNA positive. A total of 693 laboratory-confirmed FluA-p patients"/>
  <result pre="patients hospitalized with Flu-p in China, 2013–2019. 3190 patients with" exact="influenza" post="RNA positive were screened. Totally, 693 laboratory-confirmed FluA-p patients"/>
  <result pre="More than 50% had at least one underlying disease, including" exact="cardiovascular disease" post="24.0% (259/1079), diabetes mellitus 11.8% (127/1079) and cerebrovascular disease"/>
  <result pre="at least one underlying disease, including cardiovascular disease 24.0% (259/1079)," exact="diabetes mellitus" post="11.8% (127/1079) and cerebrovascular disease 9.0% (97/1079). In total,"/>
  <result pre="hospitalization, whilst 23.1% (249/1079), 24.6% (265/1079) and 4.9% (53/1079) developed" exact="respiratory failure," post="heart failure and septic shock, respectively. In total, 17.9%"/>
  <result pre="were younger and predominantly male. In FluA-p patients, cerebrovascular disease," exact="diabetes mellitus" post="and smoking history were frequent, whilst cardiovascular disease was"/>
  <result pre="cerebrovascular disease, diabetes mellitus and smoking history were frequent, whilst" exact="cardiovascular disease" post="was less common. FluA-p patients more frequently showed axillary"/>
  <result pre="clinical outcomes of flu-p patients Univariate logistic analysis showed that" exact="influenza" post="A virus infection was associated with an increased risk"/>
  <result pre="in Flu-p patients (Table 3). Table 3 The impact of" exact="influenza" post="virus type A on the illness severity and outcomes"/>
  <result pre="corticosteroid use, and coinfections, multivariate logistic regression models revealed that" exact="influenza" post="A virus infection was associated with an increased risk"/>
  <result pre="patients (Table 3). The forrest plots of the impact of" exact="influenza" post="virus A on invasive ventilation, admittance to the ICU"/>
  <result pre="Fig. 2. Fig. 2 Forrest plot of the impact of" exact="influenza" post="virus type on the illness severity and outcomes of"/>
  <result pre="hospitalized with Flu-p in China, 2013–2019. Before adjusting for confounders," exact="influenza" post="A virus infection was associated with an increased risks"/>
  <result pre="did not correlate with 30-day mortality. After adjusting for confounders," exact="influenza" post="A virus infection was associated with an increased risks"/>
  <result pre="factors screened in the univariate analysis with P &amp;lt;  0.1 and" exact="influenza" post="A virus infection were added to the Cox regression"/>
  <result pre="model (Additional file 1). Multivariate Cox regression models confirmed that" exact="influenza" post="A virus infection (hazard ratio [HR]: 2.637, 95% CI:"/>
  <result pre="1.134–6.131, P = 0.024), age (HR: 1.055, 95% CI: 1.033–1.077, P &amp;lt;  0.001)," exact="cardiovascular disease" post="(HR: 7.683, 95% CI: 3.175–18.58, P &amp;lt;  0.001), smoking history"/>
  <result pre="than that of FluB-p patients after adjusting for confounders (age," exact="cardiovascular disease," post="chronic kidney disease, smoking history, confusion, lymphocytes &amp;lt; 0.8 × 109/L, hemoglobin"/>
  <result pre="of FluB-p patients after adjusting for confounders (age, cardiovascular disease," exact="chronic kidney disease," post="smoking history, confusion, lymphocytes &amp;lt; 0.8 × 109/L, hemoglobin &amp;lt; 100 g/L, BUN &amp;gt; 7 mmol/L,"/>
  <result pre="after adjusting for potential confounders, suggesting a direct impact of" exact="influenza" post="virus types on the characteristics and outcomes of influenza"/>
  <result pre="of influenza virus types on the characteristics and outcomes of" exact="influenza" post="related pneumonia. In this study, the 30-day mortality was"/>
  <result pre="patients with flu B infection. After adjustment for age, sex," exact="heart disease," post="malignancies and time from illness onset to antiviral treatment,"/>
  <result pre="Chaves and colleagues [21] performed a retrospective study using population-based" exact="influenza" post="hospitalization surveillance data. They found that A (H1N1) pdm09"/>
  <result pre="been elucidated, some mechanisms have been postulated. Hemagglutinin (HA) of" exact="influenza" post="B virus strains is heavily glycosylated [23]. Since glycosylated"/>
  <result pre="it is easily cleared from the lungs. HA of human" exact="influenza" post="B viruses also preferentially bind to α-2,6-linked sialic acids"/>
  <result pre="more prevalent in the lower respiratory tract [25]. Compared to" exact="influenza" post="A viruses, influenza B has lower receptor-binding affinity due"/>
  <result pre="the lower respiratory tract [25]. Compared to influenza A viruses," exact="influenza" post="B has lower receptor-binding affinity due to the presence"/>
  <result pre="The innate IFN response is also more rapidly initiated following" exact="influenza" post="B as opposed to influenza A virus infection. This"/>
  <result pre="also more rapidly initiated following influenza B as opposed to" exact="influenza" post="A virus infection. This leads to more rapid viral"/>
  <result pre="viral clearance and lower viral titers [27]. In vivo, both" exact="influenza" post="A and B viruses downregulate the surface expression of"/>
  <result pre="more pronounced reduction in surface MHC-I expression was observed in" exact="influenza" post="B patients, leading to milder immunologic reactions, followed by"/>
  <result pre="risk factor for death. They further confirmed that prior chronic" exact="respiratory disease" post="was associated with ICU admission in multivariate logistic regression"/>
  <result pre="admission in multivariate logistic regression models. The proportion of chronic" exact="respiratory disease" post="patients was significantly higher in flu A compared to"/>
  <result pre="the post-pandemic period was more related to poor outcomes (secondary" exact="bacterial pneumonia," post="ICU admission, and death) than influenza B viruses [33]."/>
  <result pre="poor outcomes (secondary bacterial pneumonia, ICU admission, and death) than" exact="influenza" post="B viruses [33]. To our knowledge, this is the"/>
  <result pre="hospital wards or ICUs) that focused on the association of" exact="influenza" post="viruses types with illness severity and clinical outcomes of"/>
  <result pre="types with illness severity and clinical outcomes of laboratory-confirmed influenza-related" exact="pneumonia" post="patients. Methods were taken to reduce selection bias and"/>
  <result pre="bias may have influenced the data. For example, during each" exact="influenza" post="season, patients with influenza-like illness (such as fever, sore"/>
  <result pre="(such as fever, sore throat or cough) were assessed through" exact="influenza" post="RNA tests by the subjective judgement of attending physicians"/>
  <result pre="our results. Thirdly, there is evidence of different severities of" exact="influenza" post="A virus subtypes [11, 32]. However, over 50% of"/>
  <result pre="of FluA-p are worse than FluB-p, highlighting the importance of" exact="influenza" post="virus strain testing in the management of severe influenza."/>
  <result pre="virus strain testing in the management of severe influenza. As" exact="influenza" post="A virus infection is a predictor for poor outcomes"/>
  <result pre="with FluA-p. Also, it suggests the priority of vaccination covered" exact="influenza" post="virus type A strains in certain populations is rational."/>
  <result pre="Abbreviations BUN Blood urea nitrogen CI Interval confidence Flu-p Influenza-related" exact="pneumonia" post="HR Hazard ratio ICU Intensive care unit IQR Interquartile"/>
  <result pre="authors declare no competing interests. References References 1.ThommesEWKruseMKohliMSharmaRNoorduynSGReview of seasonal" exact="influenza" post="in Canada: burden of disease and the cost-effectiveness of"/>
  <result pre="Canada: burden of disease and the cost-effectiveness of quadrivalent inactivated" exact="influenza" post="vaccinesHum Vaccin Immunother20171386787610.1080/21645515.2016.125153727858509 2.LozanoRNaghaviMForemanKLimSShibuyaKAboyansVet al.Global and regional mortality from"/>
  <result pre="burden of disease study 2010Lancet.20123802095212810.1016/S0140-6736(12)61728-023245604 3.LySArashiroTIengVTsuyuokaRParryAHorwoodPet al.Establishing seasonal and alert" exact="influenza" post="thresholds in Cambodia using the WHO method: implications for"/>
  <result pre="Cambodia using the WHO method: implications for effective utilization of" exact="influenza" post="surveillance in the tropics and subtropicsWestern Pac Surveill Response"/>
  <result pre="tropics and subtropicsWestern Pac Surveill Response J20178223210.5365/wpsar.2017.8.1.00228409056 4.ReedCChavesSSDaily KirleyPEmersonRAragonDHancockEBet al.Estimating" exact="influenza" post="disease burden from population-based surveillance data in the United"/>
  <result pre="9.MosnierACainiSDaviaudINauleauEBuiTTDebostEet al.Clinical characteristics are similar across type a and B" exact="influenza" post="virus infectionsPLoS One201510e013618610.1371/journal.pone.013618626325069 10.IrvingSAPatelDCKiekeBADonahueJGVandermauseMFShayDKet al.Comparison of clinical features and"/>
  <result pre="10.IrvingSAPatelDCKiekeBADonahueJGVandermauseMFShayDKet al.Comparison of clinical features and outcomes of medically attended" exact="influenza" post="a and influenza B in a defined population over"/>
  <result pre="clinical features and outcomes of medically attended influenza a and" exact="influenza" post="B in a defined population over four seasons: 2004-2005"/>
  <result pre="through 2007-2008Influenza Other Respir Viruses20126374310.1111/j.1750-2659.2011.00263.x21668663 11.KajiMWatanabeAAizawaHDifferences in clinical features between" exact="influenza" post="a H1N1, a H3N2, and B in adult patientsRespirology2003823123310.1046/j.1440-1843.2003.00457.x12753540"/>
  <result pre="adult patientsRespirology2003823123310.1046/j.1440-1843.2003.00457.x12753540 12.FuXZhouYWuJLiuXDingCHuangCet al.Clinical characteristics and outcomes during a severe" exact="influenza" post="season in China during 2017-2018BMC Infect Dis20191966810.1186/s12879-019-4181-231357951 13.ChenLZhouFLiHXingXHanXWangYet al.Disease"/>
  <result pre="characteristics and management of hospitalised adolescents and adults with community-acquired" exact="pneumonia" post="in China: a retrospective multicentre surveyBMJ Open20188e01870910.1136/bmjopen-2017-018709 14.KossyvakisAMentisAATryfinopoulouKPogkaVKalliaropoulosAet al.Antiviral"/>
  <result pre="a retrospective multicentre surveyBMJ Open20188e01870910.1136/bmjopen-2017-018709 14.KossyvakisAMentisAATryfinopoulouKPogkaVKalliaropoulosAet al.Antiviral susceptibility profile of" exact="influenza" post="a viruses; keep an eye on immunocompromised patients under"/>
  <result pre="inhibitors in reducing mortality in patients admitted to hospital with" exact="influenza" post="a H1N1pdm09 virus infection: a meta-analysis of individual participant"/>
  <result pre="a meta-analysis of individual participant dataLancet Respir Med2014239540410.1016/S2213-2600(14)70041-424815805 16.JainSSelfWHWunderinkRGFakhranSBalkRBramleyAMet al.Community-acquired" exact="pneumonia" post="requiring hospitalization among U.S. adultsN Engl J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet"/>
  <result pre="among U.S. adultsN Engl J Med201537341542710.1056/NEJMoa150024526172429 17.MacIntyreCRChughtaiAABarnesMRiddaISealeHTomsRet al.The role of" exact="pneumonia" post="and secondary bacterial infection in fatal and serious outcomes"/>
  <result pre="secondary bacterial infection in fatal and serious outcomes of pandemic" exact="influenza" post="a(H1N1) pdm09BMC Infect Dis20181863710.1186/s12879-018-3548-030526505 18.LiuDXuJYuXTongFWallineJFuYet al.Clinical characteristics and prognosis"/>
  <result pre="a(H1N1) pdm09BMC Infect Dis20181863710.1186/s12879-018-3548-030526505 18.LiuDXuJYuXTongFWallineJFuYet al.Clinical characteristics and prognosis of" exact="influenza" post="B virus-related hospitalizations in northern China during the 2017-18"/>
  <result pre="influenza B virus-related hospitalizations in northern China during the 2017-18" exact="influenza" post="season: a multicenter case seriesBiomed Res Int20192019875656331828141 19.SohnCHRyooSMYoonJYSeoDWLimKSKimSHet al.Comparison"/>
  <result pre="clinical features and outcomes of hospitalized adult patients with novel" exact="influenza" post="a (H1N1) pneumonia and other pneumoniaAcad Emerg Med201320465310.1111/acem.1206223570478 20.WangYFanGHorbyPHaydenFLiQWuQet"/>
  <result pre="outcomes of hospitalized adult patients with novel influenza a (H1N1)" exact="pneumonia" post="and other pneumoniaAcad Emerg Med201320465310.1111/acem.1206223570478 20.WangYFanGHorbyPHaydenFLiQWuQet al.Comparative outcomes of"/>
  <result pre="Emerg Med201320465310.1111/acem.1206223570478 20.WangYFanGHorbyPHaydenFLiQWuQet al.Comparative outcomes of adults hospitalized with seasonal" exact="influenza" post="A or B virus infection: Application of the 7-category"/>
  <result pre="ordinal scaleOpen Forum Infect Dis20196ofz05330895200 21.ChavesSSAragonDBennettNCooperTD'MelloTFarleyMet al.Patients hospitalized with laboratory-confirmed" exact="influenza" post="during the 2010-2011 influenza season: exploring disease severity by"/>
  <result pre="Dis20196ofz05330895200 21.ChavesSSAragonDBennettNCooperTD'MelloTFarleyMet al.Patients hospitalized with laboratory-confirmed influenza during the 2010-2011" exact="influenza" post="season: exploring disease severity by virus type and subtypeJ"/>
  <result pre="al.Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and" exact="influenza" post="B infections depict distinct clinical pictures in ferretsPLoS One20116e2751210.1371/journal.pone.002751222110664"/>
  <result pre="pictures in ferretsPLoS One20116e2751210.1371/journal.pone.002751222110664 23.RogersGNPaulsonJCReceptor determinants of human and animal" exact="influenza" post="virus isolates: differences in receptor specificity of the H3"/>
  <result pre="based on species of originVirology198312736137310.1016/0042-6822(83)90150-26868370 24.KumlinUOlofssonSDimockKArnbergNSialic acid tissue distribution and" exact="influenza" post="virus tropismInfluenza Other Respir Viruses2008214715410.1111/j.1750-2659.2008.00051.x19453419 25.WaltherTKaramanskaRChanRWChanMCJiaNAirGet al.Glycomic analysis of"/>
  <result pre="al.Glycomic analysis of human respiratory tract tissues and correlation with" exact="influenza" post="virus infectionPLoS Pathog20139e100322310.1371/journal.ppat.100322323516363 26.MatrosovichMNGambaryanASTuzikovABByramovaNEMochalovaLVGolbraikhAAet al.Probing of the receptor-binding sites"/>
  <result pre="al.Probing of the receptor-binding sites of the H1 and H3" exact="influenza" post="a and influenza B virus hemagglutinins by synthetic and"/>
  <result pre="receptor-binding sites of the H1 and H3 influenza a and" exact="influenza" post="B virus hemagglutinins by synthetic and natural sialosidesVirology.199319611112110.1006/viro.1993.14598356788 27.ÖsterlundPStrengellMSarinLPPoranenMMFagerlundRMelénKet"/>
  <result pre="B virus hemagglutinins by synthetic and natural sialosidesVirology.199319611112110.1006/viro.1993.14598356788 27.ÖsterlundPStrengellMSarinLPPoranenMMFagerlundRMelénKet al.Incoming" exact="influenza" post="a virus evades early host recognition, while influenza B"/>
  <result pre="27.ÖsterlundPStrengellMSarinLPPoranenMMFagerlundRMelénKet al.Incoming influenza a virus evades early host recognition, while" exact="influenza" post="B virus induces interferon expression directly upon entryJ Virol201286111831119310.1128/JVI.01050-1222855501"/>
  <result pre="entryJ Virol201286111831119310.1128/JVI.01050-1222855501 28.KoutsakosMMcWilliamHEGAktepeTEFritzlarSIllingPTMifsudNAet al.Downregulation of MHC class I expression by" exact="influenza" post="a and B virusesFront Immunol201910115810.3389/fimmu.2019.0115831191533 29.LoubetPSamih-LenziNGaltierFVanhemsPLoulerguePDuvalXet al.Factors associated with"/>
  <result pre="29.LoubetPSamih-LenziNGaltierFVanhemsPLoulerguePDuvalXet al.Factors associated with poor outcomes among adults hospitalized for" exact="influenza" post="in France: a three-year prospective multicenter studyJ Clin Virol201679687310.1016/j.jcv.2016.04.00527105315"/>
  <result pre="Virol201679687310.1016/j.jcv.2016.04.00527105315 30.SuSChavesSSPerezAD'MelloTKirleyPDYousey-HindesKet al.Comparing clinical characteristics between hospitalized adults with laboratory-confirmed" exact="influenza" post="a and B virus infectionClin Infect Dis20145925225510.1093/cid/ciu26924748521 31.WieSHSoBHSongJYCheongHJSeoYBChoiSHet al.A"/>
  <result pre="the clinical and epidemiological characteristics of adult patients with laboratory-confirmed" exact="influenza" post="a or B during the 2011-2012 influenza season in"/>
  <result pre="patients with laboratory-confirmed influenza a or B during the 2011-2012" exact="influenza" post="season in Korea: a multi-center studyPLoS One20138e6268510.1371/journal.pone.006268523671624 32.IshiguroTTakayanagiNKanauchiTUozumiRKawateETakakuYet al.Clinical"/>
  <result pre="a multi-center studyPLoS One20138e6268510.1371/journal.pone.006268523671624 32.IshiguroTTakayanagiNKanauchiTUozumiRKawateETakakuYet al.Clinical and radiographic comparison of" exact="influenza" post="virus-associated pneumonia among three viral subtypesIntern Med20165573173710.2169/internalmedicine.55.522727041156 33.CainiSKronemanMWiegersTEl Guerche-SéblainCPagetJClinical"/>
  <result pre="studyPLoS One20138e6268510.1371/journal.pone.006268523671624 32.IshiguroTTakayanagiNKanauchiTUozumiRKawateETakakuYet al.Clinical and radiographic comparison of influenza virus-associated" exact="pneumonia" post="among three viral subtypesIntern Med20165573173710.2169/internalmedicine.55.522727041156 33.CainiSKronemanMWiegersTEl Guerche-SéblainCPagetJClinical characteristics and"/>
  <result pre="three viral subtypesIntern Med20165573173710.2169/internalmedicine.55.522727041156 33.CainiSKronemanMWiegersTEl Guerche-SéblainCPagetJClinical characteristics and severity of" exact="influenza" post="infections by virus type, subtype, and lineage: a systematic"/>
 </snippets>
</snippetsTree>
